Heterogeneity of SSTR2 Expression Assessed by <sup>68</sup>Ga-DOTATOC PET/CT Using Coefficient of Variation in Patients with Neuroendocrine Tumors
Rosa Fonti(Institute of Biostructure and Bioimaging), Silvana Del Vecchio(Federico II University Hospital), Armin Hakkak Moghadam Torbati(University of Naples Federico II), Mariarosaria Panico(Institute of Biostructure and Bioimaging), Alessandro Pulcrano(University of Naples Federico II), Mario Giuliano(Regione Campania), Luisa Alessia Vastarella(University of Naples Federico II), Sara Pellegrino(University of Milan), Sabino De Placido, Giovannella Palmieri(Regione Campania)
Cited by 30
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials
|Journal of Clinical Oncology|2007|413
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
|Cancer Treatment Reviews|2018|282
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273